Deep Track Biotechnology Master Fund, Ltd.

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
George Town, Cayman Islands
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Deep Track Biotechnology Master Fund, Ltd. /s/ David Kroin, Director
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Deep Track Biotechnology Master Fund, Ltd.

Form 4 holding 10%+ Owner

LB PHARMACEUTICALS INC

Security class
Pre-Funded Warrants (Right to Buy)
Shares / value
664,649
Estimated value
$23,222,769
Report date
30 Jul 2026
Price
$34.94
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

LB PHARMACEUTICALS INC

Security class
Pre-Funded Warrants (Right to Buy)
Shares / value
93,925
Estimated value
$1,988,382
Report date
30 Jul 2026
Price
$21.17
Ownership
By Deep Track Special Opportunities Fund, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

LB PHARMACEUTICALS INC

Security class
Common Stock
Shares / value
2,686,138
Estimated value
Report date
12 Sep 2025
Price
Ownership
Direct
Form 4 holding 10%+ Owner

LB PHARMACEUTICALS INC

Security class
Common Stock
Shares / value
666,666
Estimated value
Report date
12 Sep 2025
Price
Ownership
By Deep Track Special Opportunities Fund, LP
Form 4 holding 10%+ Owner

LB PHARMACEUTICALS INC

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
12 Sep 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Deep Track Biotechnology Master Fund, Ltd.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .